Suspension of trading
Valuation Decoy Therapeutics Inc. Börse Stuttgart
Stocks
FP11
US79400X6022
Biotechnology & Medical Research
|
Delayed
Börse Stuttgart
18:48:59 14/06/2024 +03
|
5-day change | 1st Jan Change | ||
| 3.104 EUR | -3.96% |
|
+704.15% | +435.17% |
Company Valuation: Decoy Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22.39 | 3.485 | 2.56 | 2.652 | 4.142 | 1.16 | - |
| Change | - | -84.43% | -26.55% | 3.58% | 56.21% | -72% | - |
| Enterprise Value (EV) | 22.39 | 3.485 | 2.56 | 2.652 | 4.142 | 1.16 | 1.16 |
| Change | - | -84.43% | -26.55% | 3.58% | 56.21% | -72% | 0% |
| P/E | -1.6x | - | -0.17x | -0.32x | -0.06x | -0.2x | -0.21x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | - | - | 0x | 0x | 0x | 0.03x |
| Capitalization / Revenue | 12,167,670x | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | -0x | -0.11x | -0.06x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -11,160 | - | -5,530 | -1,042 | -129.1 | -8.96 | -8.28 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales | 1.84 | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| EBIT 1 | - | - | - | - | -12.61 | -10.2 | -19.1 |
| Net income 1 | -12.77 | -31.61 | -12.54 | -5.576 | -12.52 | -10.1 | -19.1 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 17,841.586 | 2,203.200 | 936.000 | 331.200 | 7.786 | 1.770 | 1.770 |
| Nbr of stocks (in thousands) | 1.26 | 1.58 | 2.74 | 8.01 | 532 | 655.2 | - |
| Announcement Date | 3/10/22 A | 3/27/23 A | 3/22/24 A | 3/21/25 A | 3/31/26 A | - | - |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 20.98x | 31.37x | 12.47x | 0.31% | 43.39B | |
| Weighted average by Cap. | 22.27x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DCOY Stock
- FP11 Stock
- Valuation Decoy Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
